Detalhe da pesquisa
1.
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials.
Clin Gastroenterol Hepatol
; 21(3): 723-731.e9, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750249
2.
Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.
Pain Med
; 24(3): 341-350, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102822
3.
Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.
Curr Ther Res Clin Exp
; 98: 100694, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875317
4.
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
J Emerg Med
; 62(2): 231-239, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893381
5.
P029 Pharmacokinetic/Pharmacodynamic Analysis of Amiselimod, a Selective Sphingosine 1-Phosphate Receptor Modulator, in Healthy Subjects: Results From a Phase 1 Study.
Am J Gastroenterol
; 116(Suppl 1): S7, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461948
6.
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
Support Care Cancer
; 29(9): 5209-5218, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629189
7.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742767
8.
Immunogenicity and skin clearance recapture in clinical studies of brodalumab.
J Am Acad Dermatol
; 82(2): 344-351, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175910
9.
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Prostate
; 79(6): 604-613, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663074
10.
Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials
J Drugs Dermatol
; 18(10): 1012-1018, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584780
11.
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials.
J Am Acad Dermatol
; 78(1): 81-89.e5, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985956
12.
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
J Am Acad Dermatol
; 79(2): 287-293, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29614243
13.
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.
J Drugs Dermatol
; 17(10): 1062-1069, 2018 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365586
14.
Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
J Drugs Dermatol
; 17(8): 855-861, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124724
15.
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
Pain Med
; 18(8): 1496-1504, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28810695
16.
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
Pain Pract
; 17(6): 820-828, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27860208
17.
Untangling the relatedness among correlations, part I: Nonparametric approaches to inter-subject correlation analysis at the group level.
Neuroimage
; 142: 248-259, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27195792
18.
Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis.
J Am Acad Dermatol
; 80(1): 282-285, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30227193
19.
Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication.
Cureus
; 16(1): e52174, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344544
20.
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.
Clin Transl Sci
; 16(1): 165-174, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326174